Hereditary colorectal cancer: clinical consequences of predictive molecular testing
β Scribed by M. Hahn; H. -D. Saeger; H. K. Schackert
- Publisher
- Springer
- Year
- 1999
- Tongue
- English
- Weight
- 405 KB
- Volume
- 14
- Category
- Article
- ISSN
- 0179-1958
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Predictive genetic testing for cancer allows identification of those with the mutation (mutation positive) who should undergo cancer surveillance aiming at early detection of cancer and those without the mutation (mutation negative), whose unnecessary worry can be alleviated and who need not undergo
The aim of this prospective study was to assess the uptake of predictive genetic testing for hereditary non-polyposis colorectal cancer (HNPCC) and its associations with sociodemographic and other factors, and long-term satisfaction with taking the test. The test was offered to all high-risk members
Lynch syndrome, or hereditary nonpolyposis colon cancer (HNPCC), is an autosomaldominant disease accounting for approximately 1 5 % of all colorectal cancer cases. Due to the lack of pathognomonic morphological or biomolecular markers, HNPCC has traditionally posed unique problems to clinicians and
We thank Ms. Jeanne Wenger and Ms. Linda M. Welch for secretarial assistance.
Hereditary nonpolyposis colorectal carcinoma (HNPCC) is the most common hereditary form of colorectal carcinoma (CRC) and may account for 5-10% of the total CRC burden. The discovery of DNA mismatch repair (MMR) genes, inclusive of hMSH2, hMLH1, hPMS2, and hMSH6, has enabled the identification of wh